FDA Advisory Committee Meeting To Review Egrifta – The Food and Drug Administration (FDA) will hold a public meeting to discuss the safety and efficacy of Egrifta (tesamorelin), a drug under development and submitted for FDA approval by Theratechnologies, Inc. The proposed use for Egrifta is to induce and maintain a reduction of excess abdominal fat in HIV patients with lipodystrophy, a condition in which abnormal deposits of fat result from using certain HIV treatments. The meeting will be held on May 27 from 8 a.m. to 5 p.m. at The Inn and Conference Center at the University of Maryland University College, Adelphi, MD. No registration is required. For more information, please see the FDA press release.

Documentary Raises Awareness About HIV Among Latina Women – This past summer, a junior at the University of Houston, Erica Fletcher, spent one month researching and filming her documentary “Marianismo.” In her documentary, she attempts to capture the cultural factors that may explain the disproportionate number of Latina women who live with HIV. The 20-minute final version of “Marianismo” centers around Fletcher’s interviews with three HIV-positive Latina women in the Houston area. For more information about Fletcher’s “Marianismo,” please see the article by The Daily Cougar, a University of Houston student newspaper.

AIDS Activists From Haiti Participate In Panel – A public panel and discussion titled “Keith D. Cylar Activist Awards and Panel: Addressing AIDS In Haiti After the Earthquake” will focus on post-earthquake efforts and will feature five Haiti-based AIDS activists affiliated with Haiti’s national AIDS coalition PHAP+. The event will be held on April 1 from 6 p.m. to 8 p.m at Lang Cafe at the New School in New York City. For more information about the panel and the activists, please see the Housing Works press release.

For a more detailed listing of HIV/AIDS related events, please check the AIDS Beacon Events Calendar.